您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
CDK4 Recombinant Rabbit mAb (S-685-210)

CDK4 Recombinant Rabbit mAb (S-685-210)

货号: S0B0938
价格: 600
规格: 25μl
介绍: -
其他: -
产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    CDK4
  • 分子别名

    Cyclin-dependent kinase 4, Cell division protein kinase 4, PSK-J3
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cytoplasm, Nucleus
  • Accession

    P11802
  • 克隆号

    S-685-210
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 应用

    ICFCM, ICC, WB
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

稀释度
应用 稀释度
WB 1:1000
ICC 1:500
ICFCM 1:500
背景介绍
  • The CDK4 protein, or cyclin-dependent kinase 4, is a crucial regulator of the cell cycle, particularly in the G1 phase. It is a protein kinase that, in complex with cyclin D, phosphorylates the retinoblastoma tumor suppressor protein (pRb), leading to cell cycle progression from the G1 phase to the S phase. This process is essential for cell growth and division. CDK4 is often dysregulated in cancer, with overexpression or hyperactivity contributing to uncontrolled cell proliferation. Mutations in CDK4 can lead to its constitutive activation, which has been implicated in various types of cancer, including melanoma, glioblastoma, and breast cancer. The CDK4/6 inhibitors, such as palbociclib, ribociclib, and abemaciclib, have been developed as targeted therapies to treat certain breast cancers by inhibiting the activity of CDK4/6, thereby blocking cell cycle progression.

  • 免疫印迹

    • WB result of CDK4 Recombinant Rabbit mAb
      Primary antibody: CDK4 Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: Jurkat whole cell lysate 20 µg
      Lane 2: HeLa whole cell lysate 20 µg
      Lane 3: MCF7 whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 34 kDa
      Observed MW: 30 kDa

  • 流式分析

    • Flow cytometric analysis of 4% PFA fixed 90% methanol permeabilized HeLa (Human cervix adenocarcinoma epithelial cell) labelling CDK4 antibody at 1/500 dilution (0.1 μg) / (Red) compared with a Rabbit monoclonal IgG (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Rabbit IgG Alexa Fluor® 488 was used as the secondary antibody.

    • Flow cytometric analysis of 4% PFA fixed 90% methanol permeabilized MCF7 (Human breast adenocarcinoma epithelial cell) labelling CDK4 antibody at 1/500 dilution (0.1 μg) / (Red) compared with a Rabbit monoclonal IgG (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Rabbit IgG Alexa Fluor® 488 was used as the secondary antibody.

  • 免疫细胞化学

    • ICC shows positive staining in HeLa cells. Anti-CDK4 antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

    • ICC shows positive staining in MCF7 cells. Anti-CDK4 antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).